Vaginal contraceptives. Effective protection from sexually transmitted diseases for women?
North, B.B.
Journal of Reproductive Medicine 33(3): 307-311
1988
ISSN/ISBN: 0024-7758 PMID: 2834553 Document Number: 322198
The use of vaginal contraceptives reduces the risk of a woman's contracting sexually transmitted diseases (STDs). Almost two decades of laboratory data have established the virucidal and bactericidal characteristics of the spermicide nonoxynol-9; clinical trials, albeit limited, have confirmed its effectiveness. The use of spermicides in conjunction with mechanical barriers, such as the condom, diaphragm, contraceptive sponge and cervical cap, may provide optimal STD prophylaxis. Such information should be conveyed to women who are at risk of contracting or transmitting STDs.
Document emailed within 1 workday
Related Documents
North, B.B. 1988: Vaginal contraceptives. Effective protection from sexually transmitted diseases for women? Journal of Reproductive Medicine 33(3): 307-311North, B.B. 1990: Effectiveness of vaginal contraceptives in prevention of sexually transmitted diseases Alexander, N J , H L Gabelnick And J M Spieler (Ed ) Conrad Workshop Series: Heterosexual Transmission Of Aids; Second Contraceptive Research And Development (Conrad) Program International Workshop, Norfolk, Virginia, Usa, February 1-3, 1989 Xiv+440p Wiley-Liss: New York, New York, Usa Illus Maps 273-290
Johnson, H.L.; Erbelding, E.J.; Zenilman, J.M.; Ghanem, K.G. 2007: Sexually transmitted diseases and risk behaviors among pregnant women attending inner city public sexually transmitted diseases clinics in Baltimore, MD, 1996-2002 Sexually Transmitted Diseases 34(12): 991-994
Johnson, H.L.; Erbelding, E.J.; Zenilman, J.M.; Ghanem, K.G. 2007: Sexually transmitted diseases and risk behaviors among pregnant women attending inner city public sexually transmitted diseases clinics in Baltimore, MD, 1996-2002 Sexually Transmitted Diseases 34(12): 991-994
Johnson, H.L.; Erbelding, E.J.; Zenilman, J.M.; Ghanem, K.G. 2007: Sexually transmitted diseases and risk behaviors among pregnant women attending inner city public sexually transmitted diseases clinics in Baltimore, MD, 1996-2002 Sexually Transmitted Diseases 34(12): 991-994
Ben Aissa-Hamzaoui, R.; Kouki, S.; Ben Hamida, A.; Kechrid, A.; Gueddana, N. 1999: Prevalence of sexually transmitted diseases among pregnant Tunisian women and validation of a clinical algorithm proposed by WHO for the management of sexually transmitted diseases Contraception Fertilite Sexualite 27(11): 785-790
Ben Aissa-Hamzaoui, R.; Kouki, S.; Ben Hamida, A.; Kechrid, A.; Gueddana, N. 1999: Prevalence of sexually transmitted diseases among pregnant Tunisian women and validation of a clinical algorithm proposed by WHO for the management of sexually transmitted diseases Contraception Fertilite Sexualite 27(11): 785-790
Clark, R.A.; Kissinger, P.; Williams, T. 1996: Contraceptive and sexually transmitted diseases protection among adult and adolescent women infected with human immunodeficiency virus International Journal of Std and Aids 7(6): 439-442
Johnson, H.L.; Ghanem, K.G.; Zenilman, J.M.; Erbelding, E.J. 2011: Sexually transmitted infections and adverse pregnancy outcomes among women attending inner city public sexually transmitted diseases clinics Sexually Transmitted Diseases 38(3): 167-171
Johnson, H.L.; Ghanem, K.G.; Zenilman, J.M.; Erbelding, E.J. 2011: Sexually transmitted infections and adverse pregnancy outcomes among women attending inner city public sexually transmitted diseases clinics Sexually Transmitted Diseases 38(3): 167-171
Baxter, C.E.; Barata, P.C. 2011: The paradox of HPV vaccines: how to reach sexually inexperienced women for protection against a sexually transmitted infection Women's Health Issues: Official Publication of the Jacobs Institute of Women's Health 21(3): 239-245
Van den Brûle, F. 1999: Vaginal infections and sexually transmitted diseases Revue Medicale de Liege 54(4): 296-302
Chernesky, M.A. 1997: How can industry, academia, public health authorities, and the sexually transmitted diseases diagnostics initiative work together to help control sexually transmitted diseases in developing countries? Sexually Transmitted Diseases 24(2): 61-63
Chernesky, M.A. 1997: How can industry, academia, public health authorities, and the sexually transmitted diseases diagnostics initiative work together to help control sexually transmitted diseases in developing countries? Sexually Transmitted Diseases 24(2): 61-63
Chernesky, M.A. 1997: How can industry, academia, public health authorities, and the sexually transmitted diseases diagnostics initiative work together to help control sexually transmitted diseases in developing countries? Sexually Transmitted Diseases 24(2): 61-63
Felman, Y.M. 1990: I. Recent advances in sexually transmitted diseases: reflections on the Center for Disease Control's new sexually transmitted diseases treatment guidelines from the viewpoint of a private practitioner Cutis 45(3): 149-150
Chernesky, M.A. 1997: How can industry, academia, public health authorities, and the sexually transmitted diseases diagnostics initiative work together to help control sexually transmitted diseases in developing countries? Sexually Transmitted Diseases 24(2): 61-63
Gateau, T.; Zeller, H.G. 1996: Epidemiological approach for sexually transmitted diseases in Antsiranana (north Madagascar). Between prevention and treatment, the choice of a strategy against sexually transmitted diseases Archives de l'Institut Pasteur de Madagascar 63(1-2): 8-11
Rosenfeld; Bassoon Swedler J 1992: Role of Hormonal Contraceptives in Prevention of Pregnancy and Sexually Transmitted Diseases Adolescent Medicine 3(2): 207-222
Thior, I.; Diouf, G.; Diaw, I.K.; Sarr, A.D.; Hsieh, C.C.; Ndoye, I.; Mboup, S.; Chen, L.; Essex, M.; Marlink, R.; Kanki, P. 1997: Sexually transmitted diseases and risk of HIV infection in men attending a sexually transmitted diseases clinic in Dakar, Senegal African Journal of Reproductive Health 1(2): 26-35